On June 24, 2019, Pankaj Mohan, Ph.D., notified Outlook Therapeutics, Inc. of his decision not to stand for re-election to the Board of Directors of the Company (the “Board”) at the 2019 annual meeting of stockholders of the Company (the “Annual Meeting”), and his resignation as a Class III director will be effective at the end of his current term at the Annual Meeting. Dr. Mohan indicated that his decision not to stand for re-election and his resignation from the Board was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.